Menu Back to DIA-China-8th-Annual-Meeting

Overview

The DIA China Annual Meeting as the largest interdisciplinary event in Asia that brings together a global network of life sciences professionals to foster innovation that leads to the development of safe and effective products and therapies to patients.

Professionals at all levels involved in the drug discovery, development, and life cycle management of health care products, will travel from China and around the world to share their views, knowledge, experience, and cross-functional content with real-world application.

DIA China Annual Meeting had attracted nearly 1900 attendees in 2015 and will continue to be your essential partner to update knowledge and help to accelerate heath care product development.

Register

Featured topics

  • CFDA Townhall
  • Special Forum – Enabling Key Capability for Innovation in China
  • Rapid Evolving China Regulatory Science – Seize the Opportunity for Driving Innovation
  • Develop Innovative Solution to Fill the Unmet Medical Needs in China – Special Focuses on Oncology, Diabetes, Cardiovascular and HCV/HBV
  • Operational Excellence – China’s Own Challenges and Unique Opportunity
  • Clinical Trial Sites in China – Bottleneck or the Anchor for Quality Clinical Trials
  • Quantitative Science – The Backbone of Evidence Based Data Generation
  • CMC & Generic Drug
  • Biologics & Biosimilar Development
  • Medical Affairs – MSLs, Marketing New Model Engagement, Compliance and Market Access
  • Key Elements in Successful Drug Activities – Medical Writing and Project Management
  • Safety Surveillance  
  • Quality System – from the Regulator, Site and Investigator's Perspectives
  • Early Stage Drug Development
  • CRO, SMO & Investigator
  • Informational Technology  -- Long Distance, Mobile Medicine & Documentation
  • Hot Topics and Late Breaker – Medical Devices and Rare Diseases 
  • Program Committee

    • Jingsong  WANG, MD
      Jingsong WANG, MD
      China
    • Haifeng  Cao
      Haifeng Cao Regulatory Affairs Director
      Boehringer Ingelheim Co. Ltd, China
    • Lili  Cao, MS
      Lili Cao, MS Director of Division of External Cooperation
      China Center for Food and Drug International Exchange of CFDA , China
    • Xiaochun  Cao
      Xiaochun Cao General Manager
      Hangzhou Simo Co., Ltd., China
    • George  Chen, MD, MBA
      George Chen, MD, MBA VP and Head of Global Medicine Development China
      AstraZeneca, China
    • Paul  Dai, MD
      Paul Dai, MD Senior Director, Regional Head of ICRO AMAC & Greater China Region
      Beijing Novartis Pharma Co., Ltd., China
    • Yazhong  Deng, MBA
      Yazhong Deng, MBA Director, Clinical Data, Analysis and Reporting organization
      Trust CRO, China
    • Frank  Fan, PhD
      Frank Fan, PhD Senior Medical Director
      Sanofi, China
    • Tony  Guo
      Tony Guo Associate Biostatistics Manager
      Sanofi-aventis (China) Investment Co., Ltd, China
    • Min Wang Irwin, MD, PhD
      Min Wang Irwin, MD, PhD VP, Medicines Development
      GlaxoSmithKline, China
    • Amy  Jiang
      Amy Jiang Quality Operations Head, China R&D
      Sanofi, China
    • Helen  Li, MD, MBA
      Helen Li, MD, MBA Director, Emerging Market QA Asia Lead
      Pfizer Medical, China
    • Joy  Li
      Joy Li Director of pharmacovigilance and medical information
      BMS China R&D, China
    • Shuting  LI, MD
      Shuting LI, MD Director, GCP Center
      Cancer Institute & Hospital, Chinese Academy of Medical Sciences, China
    • Vera  Liang, MD
      Vera Liang, MD Director and Global Safety Risk Lead, Safety Surveillance and Risk Management
      Pfizer (China) R&D Co., Ltd., China
    • Jane  LIN, MD
      Jane LIN, MD VP, Strategic Medical Affairs
      Johnson & Johnson Medical (China) Ltd., China
    • Melly  Lin
      Melly Lin Regulatory Manager
      Roche (China) Holding Ltd., China
    • Jessica  Liu
      Jessica Liu VP Clinical Development, General Medicine BU, Asia-Pacific Region
      INC Research, China
    • Roger (Peng)  Qu, PhD
      Roger (Peng) Qu, PhD Head of Clinical Statistics
      Pfizer China R&D Center, China
    • Hualong  Sun
      Hualong Sun General manager
      Meta Clinical Technology, China
    • Xiaoling  Wang
      Xiaoling Wang Sr. Manager
      Clinical Documentation, Sanofi R&D, China
    • Xiuqin  Wang, MD
      Xiuqin Wang, MD Vice Director of Scientific Research Dept.
      Jiangsu Province Hospital, China
    • Jielai  Xia, PhD
      Jielai Xia, PhD Professor
      4th Military Medical University, China
    • Jack  Xu, MD, MS
      Jack Xu, MD, MS Senior Vice President
      Shanghai Clinical Research Center (SCRC), China
    • Charles  Yan
      Charles Yan
      Jiangsu Hengrui Medicine Co., Ltd., China
    • James  Yan
      James Yan Executive Vice President, Head of Early Development and Drug Safety,
      Zai Lab, China
    • Wendy  Yan, MD, MBA
      Wendy Yan, MD, MBA Head of Regulatory Affairs
      BeiGene (Beijing) Co., Ltd, China
    • Joe  Zhang
      Joe Zhang
      Ascenta Pharmaceuticals Ltd, China
    • Mingping  Zhang
      Mingping Zhang Principal Consultant
      PAREXEL International, China
    • Ling  Zhen
      Ling Zhen
      Quintiles, China
    • Xiaoxiang  Chen
      Xiaoxiang Chen Vice President
      Boehringer Ingelheim Shanghai Pharm. Co. Ltd, China
    • Carol  Zhu, MBA
      Carol Zhu, MBA Senior Vice President and Managing Director
      DIA China, China
    • Janet  Lu, MS
      Janet Lu, MS Head of Regulatory Asia Pacific
      Roche , China
    • Ling  Su, PhD
      Ling Su, PhD Strategic Advisor, Life Sciences
      Sidley Austin LLP, China
    • Ning  Xu, MD, MBA
      Ning Xu, MD, MBA Executive Vice President, Head of Clinical Development and Regulatory Affairs
      Zailab, China
    Load More